MedPath

Perinatal Emotion and Relationships Longitudinal Study

Completed
Conditions
Depression, Postpartum
Registration Number
NCT03027037
Lead Sponsor
University of Colorado, Boulder
Brief Summary

This study, funded by the John Templeton Foundation, will examine birth and the early postpartum period (BEPP) as a transformative life experience that may shift women's experience of emotion in such ways as to a) support enhanced other-oriented emotions and b) underlie risk or resilience from psychopathology.

Detailed Description

Specifically, the study will investigate the extent to which women can accurately have knowledge about and predict changes in self- and other-oriented emotion processes associated with BEPP. The investigators will also characterize the extent to which BEPP changes self- and other-oriented emotion processes and self- and other-oriented social behaviors. Further, the investigators will identify distinct trajectories of change in cognitive processes and self- and other-oriented emotion processes related to BEPP, and examine how those trajectories are associated with psychological adjustment (e.g., risk and relapse of psychopathology). Finally, the investigators will identify which particular features of BEPP are related to distinct patterns of change in self- and other-oriented emotion processes.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • Over age 18
  • Female
  • Currently pregnant - approximately no more than 34 weeks gestational age
  • Able to read and write in English fluently
  • MDD Group: Meet DSM-IV/DSM-5 criteria for at least 1 past episode of Major Depressive Disorder
  • MDD Group: DO NOT meet DSM-IV/DSM-5 criteria for any episodes of Major Depressive Disorder in past 2 months (currently in symptom remission)
Exclusion Criteria
  • Previous birth to a living child (i.e., this pregnancy is not their first child)
  • Imminently suicidal or homicidal
  • History of severe head trauma, stroke, neurological disease
  • History of brain tumors or surgery
  • Severe medical illness (e.g., autoimmune disorder, blindness, cardiovascular disease, HIV/AIDS)
  • Endocrine disorders (e.g., Cushing's disease, thyroid disorder)
  • Alcohol/substance abuse or dependence within the past six months
  • Current psychotic episode (impairing ability to consent, participate, or keep patient and experimenter safe)
  • Inability to follow study procedures
  • CTL Group: Current or lifetime Axis I disorder (i.e., anxiety disorders, major depression, mania/hypomania, dysthymia, schizophrenia, schizoaffective disorder, substance abuse/dependence, eating disorders, hypochondriasis, pain disorder, or adjustment disorders)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prosocial behaviorThroughout study (pregnancy to 6 months postpartum)

Assessed via questionnaires and experimental tasks

Mood and anxiety symptomsThroughout study (pregnancy to 6 months postpartum)

Assessed via questionnaires

Emotion reactivity and regulationThroughout study (pregnancy to 6 months postpartum)

Assessed via questionnaires, experimental tasks, and physiological measurement

Well-being and social supportThroughout study (pregnancy to 6 months postpartum)

Assessed via questionnaires

Parenting sensitivity, efficacy, stress, bond with infantThroughout study (pregnancy to 6 months postpartum)

Assessed via questionnaires and behavioral observation

Occurrence of mood episodes and anxiety disordersThroughout study (pregnancy to 6 months postpartum)

Assessed via interview

Empathic accuracyThroughout study (pregnancy to 6 months postpartum)

Assessed via experimental tasks

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Colorado Boulder

🇺🇸

Boulder, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath